{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T18:07:59Z","timestamp":1789322879709,"version":"build-2803163510"},"reference-count":121,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grants-in-Aid for Scientific Research","award":["B, 22H03366"],"award-info":[{"award-number":["B, 22H03366"]}]},{"name":"Grants-in-Aid for Scientific Research","award":["20H03957"],"award-info":[{"award-number":["20H03957"]}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>CX3CL1 and its unique receptor, CX3CR1, are leukocyte migration factors and are involved in the pathogenesis and progression of many inflammatory diseases and malignancies. The CX3CL1-CX3CR1 axis induces a variety of responses, including cell proliferation, migration, invasion, and apoptosis resistance. CX3CL1 is a transmembrane protein, and proteolysis generates a soluble form. The membrane and soluble forms of CX3CL1 exhibit different functions, but both bind to the chemokine receptor CX3CR1. The CX3CL1-CX3CR1 axis is a chemokine system that has attracted attention not only as a therapeutic target but also as a potentially useful diagnostic and prognostic marker for disease. Many studies have reported that the CX3CL1-CX3CR1 axis is involved in disease progression, but more recently there are scattered reports suggesting that it is involved in disease suppression. In this article, we summarize the latest findings on the pathophysiological role of the CX3CL1-CX3CR1 axis, with a particular focus on renal disease, cardiovascular disease, and cancer.<\/jats:p>","DOI":"10.3390\/ijms26115352","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T03:57:18Z","timestamp":1748923038000},"page":"5352","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pathophysiological Roles of the CX3CL1-CX3CR1 Axis in Renal Disease, Cardiovascular Disease, and Cancer"],"prefix":"10.3390","volume":"26","author":[{"given":"Yuya","family":"Iwahashi","sequence":"first","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan"},{"name":"Department of Urology, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6104-7599","authenticated-orcid":false,"given":"Yuko","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Mukaida","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5059-8309","authenticated-orcid":false,"given":"Toshikazu","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"ref_1","first-page":"260","article-title":"Role of Fractalkine\/CX3CL1 and Its Receptor CX3CR1 in Allergic Diseases","volume":"32","author":"Julia","year":"2016","journal-title":"Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A New Class of Membrane-Bound Chemokine with a Cx3c Motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/art.20932","article-title":"Chemokines and Their Receptors in Rheumatoid Arthritis: Future Targets?","volume":"52","author":"Koch","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.95.18.10896","article-title":"Role for Neuronally Derived Fractalkine in Mediating Interactions between Neurons and CX3CR1-Expressing Microglia","volume":"95","author":"Harrison","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Pawelec, P., Ziemka-Nalecz, M., Sypecka, J., and Zalewska, T. (2020). The Impact of the CX3CL1\/CX3CR1 Axis in Neurological Disorders. Cells, 9.","DOI":"10.3390\/cells9102277"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.ATV.0000095360.62479.1F","article-title":"Fractalkine in Vascular Biology: From Basic Research to Clinical Disease","volume":"24","author":"Umehara","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"37993","DOI":"10.1074\/jbc.M106434200","article-title":"Tumor Necrosis Factor-Alpha-Converting Enzyme (Adam17) Mediates the Cleavage and Shedding of Fractalkine (CX3CL1)","volume":"276","author":"Garton","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mi.10.5.3","article-title":"Fractalkine\/CX3CL1: A Potential New Target for Inflammatory Diseases","volume":"10","author":"Jones","year":"2010","journal-title":"Mol. Interv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood-2002-12-3775","article-title":"The Disintegrin-like Metalloproteinase Adam10 Is Involved in Constitutive Cleavage of CX3CL1 (Fractalkine) and Regulates CX3CL1-Mediated Cell-Cell Adhesion","volume":"102","author":"Hundhausen","year":"2003","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.cell.2017.11.014","article-title":"Structural Basis for Regulated Proteolysis by the A-Secretase Adam10","volume":"171","author":"Seegar","year":"2017","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0008-6363(96)00066-1","article-title":"Molecular Mechanisms of Leukocyte Recruitment in the Inflammatory Process","volume":"32","author":"Ley","year":"1996","journal-title":"Cardiovasc. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/eci.12118","article-title":"Targeting Inflammatory Pathways in Myocardial Infarction","volume":"43","author":"Christia","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1471-4906(01)02051-8","article-title":"Fractalkine and Vascular Injury","volume":"22","author":"Umehara","year":"2001","journal-title":"Trends Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.188.8.1413","article-title":"Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow","volume":"188","author":"Fong","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.med.47.1.413","article-title":"Endothelial-Dependent Mechanisms in Chronic Inflammatory Leukocyte Recruitment","volume":"47","author":"Luscinskas","year":"1996","journal-title":"Annu. Rev. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cytogfr.2017.12.001","article-title":"Fractalkine and Placental Growth Factor: A Duet of Inflammation and Angiogenesis in Cardiovascular Disorders","volume":"39","author":"Skoda","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1074\/jbc.274.15.10053","article-title":"Molecular Uncoupling of Fractalkine-Mediated Cell Adhesion and Signal Transduction. Rapid Flow Arrest of CX3CR1-Expressing Cells Is Independent of G-Protein Activation","volume":"274","author":"Haskell","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cyto.2016.03.017","article-title":"Mosig. Recruitment of Cd16+ Monocytes to Endothelial Cells in Response to Lps-Treatment and Concomitant Tnf Release Is Regulated by CX3CR1 and Interfered by Soluble Fractalkine","volume":"83","author":"Rennert","year":"2016","journal-title":"Cytokine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/1566523218666180214092536","article-title":"CX3CL1\/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?","volume":"17","author":"Zhuang","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/14728222.2012.682574","article-title":"Therapeutic Potential of the Chemokine-Receptor Duo Fractalkine\/CX3CR1: An Update","volume":"16","author":"Friess","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1080\/14712598.2020.1764931","article-title":"Rationale for and Clinical Development of Anti-Fractalkine Antibody in Rheumatic Diseases","volume":"20","author":"Muraoka","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Cormican, S., and Griffin, M.D. (2021). Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.664202"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1517\/14728220903540265","article-title":"Fractalkine\/CX3CR1: Why a Single Chemokine-Receptor Duo Bears a Major and Unique Therapeutic Potential","volume":"14","author":"Demir","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rodriguez, C., Chocarro, L., Echaide, M., Ausin, K., Escors, D., and Kochan, G. (2024). Fractalkine in Health and Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158007"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10238-022-00888-z","article-title":"Role of Chemokines in the Crosstalk between Tumor and Tumor-Associated Macrophages","volume":"23","author":"Qin","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2174\/1389203720666190507102529","article-title":"Immune Cells in Ischemic Acute Kidney Injury","volume":"20","author":"Zheng","year":"2019","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00441-021-03473-0","article-title":"Regulation and Function of CX3CR1 and Its Ligand CX3CL1 in Kidney Disease","volume":"385","author":"Kurts","year":"2021","journal-title":"Cell Tissue Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1046\/j.1523-1755.2003.00766.x","article-title":"Tumor Necrosis Factor-Alpha Stimulates Fractalkine Production by Mesangial Cells and Regulates Monocyte Transmigration: Down-Regulation by Camp","volume":"63","author":"Chen","year":"2003","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/ndt\/gfy169","article-title":"Plasma Fractalkine Levels Are Associated with Renal Inflammation and Outcomes in Immunoglobulin a Nephropathy","volume":"34","author":"Luo","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/ki.2012.147","article-title":"Activated Innate Immunity and the Involvement of CX3CR1-Fractalkine in Promoting Hematuria in Patients with Iga Nephropathy","volume":"82","author":"Cox","year":"2012","journal-title":"Kidney Int."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Jeon, J., Park, J., Boo, H.J., Yang, K.E., Lee, C.J., Lee, J.E., Kim, K., Kwon, G.Y., Huh, W., and Kim, D.J. (2022). Clinical Value of Urinary Cytokines\/Chemokines as Prognostic Markers in Patients with Crescentic Glomerulonephritis. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-13261-7"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tang, J., Liao, Z., Luo, L., Deng, S., Jiang, Y., Wang, F., Hu, X., Yin, H., Gong, G., and Feng, J. (2022). CX3CL1-Induced Cd16+ Monocytes Extravasation in Myeloperoxidase-Anca-Associated Vasculitis Correlates with Renal Damage. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.929244"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.1010","article-title":"Fractalkine Expression in Human Renal Inflammation","volume":"196","author":"Cockwell","year":"2002","journal-title":"J. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous Murine Lupus-Like Syndromes. Clinical and Immunopathological Manifestations in Several Strains","volume":"148","author":"Andrews","year":"1978","journal-title":"J. Exp. Med."},{"key":"ref_36","first-page":"6170","article-title":"Fractalkine Mediates Lymphocyte Inflammation and Tubulointerstitial Lesions by Modifying the Treg\/Th17 Balance in Lupus-Prone Mrl\/Lpr Mice","volume":"12","author":"Fu","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1002\/art.21934","article-title":"Nephritogenic Anti-DNA Antibodies Regulate Gene Expression in Mrl\/Lpr Mouse Glomerular Mesangial Cells","volume":"54","author":"Qing","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"F207","DOI":"10.1152\/ajprenal.00482.2009","article-title":"Fractalkine Expression and Cd16+ Monocyte Accumulation in Glomerular Lesions: Association with Their Severity and Diversity in Lupus Models","volume":"299","author":"Nakatani","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00011-023-01731-1","article-title":"Cx(3)Cr1 Modulates Sle-Associated Glomerulonephritis and Cardiovascular Disease in Mrl\/Lpr Mice","volume":"72","author":"Lu","year":"2023","journal-title":"Inflamm. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/hep.27982","article-title":"CX3CR1 Is a Gatekeeper for Intestinal Barrier Integrity in Mice: Limiting Steatohepatitis by Maintaining Intestinal Homeostasis","volume":"62","author":"Schneider","year":"2015","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1681\/ASN.0000000000000083","article-title":"Chronic Kidney Disease Is Characterized by Expansion of a Distinct Proinflammatory Intermediate Monocyte Subtype and by Increased Monocyte Adhesion to Endothelial Cells","volume":"34","author":"Cormican","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.34067\/KID.0005532022","article-title":"Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study","volume":"3","author":"Corken","year":"2022","journal-title":"Kidney360"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"Tgf-\u0392: The Master Regulator of Fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and Function of Myofibroblasts in Kidney Fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8809","DOI":"10.18632\/oncotarget.6604","article-title":"Tgf-\u0392\/Smad3 Signalling Regulates the Transition of Bone Marrow-Derived Macrophages into Myofibroblasts During Tissue Fibrosis","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.ki.5002368","article-title":"Potential Role of Fractalkine Receptor Expression in Human Renal Fibrogenesis","volume":"72","author":"Koziolek","year":"2007","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"F1391","DOI":"10.1152\/ajprenal.00318.2013","article-title":"Increased Tubulointerstitial Recruitment of Human Cd141hi Clec9a+ and Cd1c+ Myeloid Dendritic Cell Subsets in Renal Fibrosis and Chronic Kidney Disease","volume":"305","author":"Kassianos","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ki.2014.407","article-title":"Fractalkine-CX3CR1-Dependent Recruitment and Retention of Human Cd1c+ Myeloid Dendritic Cells by In Vitro-Activated Proximal Tubular Epithelial Cells","volume":"87","author":"Kassianos","year":"2015","journal-title":"Kidney Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5551\/jat.11.15","article-title":"Regulation of CX3CL1\/Fractalkine Expression in Endothelial Cells","volume":"11","author":"Imaizumi","year":"2004","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2353\/ajpath.2006.060043","article-title":"Chemokine Receptor CX3CR1 Regulates Renal Interstitial Fibrosis after Ischemia-Reperfusion Injury","volume":"169","author":"Furuichi","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/eji.201040977","article-title":"Chemokine Receptor CX3CR1 Promotes Dendritic Cell Development under Steady-State Conditions","volume":"41","author":"Witzlau","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.1403209","article-title":"CX3CL1-CX3CR1 Interaction Increases the Population of Ly6c(-)CX3CR1(Hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis","volume":"195","author":"Peng","year":"2015","journal-title":"J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.4049\/jimmunol.1402149","article-title":"CX3CR1 Reduces Kidney Fibrosis by Inhibiting Local Proliferation of Profibrotic Macrophages","volume":"194","author":"Engel","year":"2015","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Jang, H.R., Kim, M., Hong, S., Lee, K., Park, M.Y., Yang, K.E., Lee, C.J., Jeon, J., Lee, K.W., and Lee, J.E. (2021). Early Postoperative Urinary Mcp-1 as a Potential Biomarker Predicting Acute Rejection in Living Donor Kidney Transplantation: A Prospective Cohort Study. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-98135-0"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.trim.2018.08.003","article-title":"Multiple-Biomarkers Provide Powerful Prediction of Early Acute Renal Allograft Rejection by Combination of Serum Fractalkine, Ifn-\u0393 and Ip-10","volume":"50","author":"Xu","year":"2018","journal-title":"Transpl. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.transproceed.2014.02.019","article-title":"Serum Fractalkine and Interferon-Gamma Inducible Protein-10 Concentrations Are Early Detection Markers for Acute Renal Allograft Rejection","volume":"46","author":"Zhang","year":"2014","journal-title":"Transplant. Proc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1365-2249.2002.01906.x","article-title":"Fractalkine Expression on Human Renal Tubular Epithelial Cells: Potential Role in Mononuclear Cell Adhesion","volume":"129","author":"Chakravorty","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.trim.2010.06.006","article-title":"Impact of Chemokine Receptor CX3CR1 in Human Renal Allograft Rejection","volume":"23","author":"Hoffmann","year":"2010","journal-title":"Transpl. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5513690","DOI":"10.1155\/2021\/5513690","article-title":"Chemokine Profiles Are Affected in Serum of Patients with Acute Rejection of Kidney Allograft","volume":"2021","author":"Krupickova","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.4049\/jimmunol.165.11.6067","article-title":"A Role for Fractalkine and Its Receptor (CX3CR1) in Cardiac Allograft Rejection","volume":"165","author":"Robinson","year":"2000","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1681\/ASN.2015010009","article-title":"Ly6chigh Monocytes Protect against Kidney Damage During Sepsis via a CX3CR1-Dependent Adhesion Mechanism","volume":"27","author":"Chousterman","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.4049\/jimmunol.181.6.4208","article-title":"Essential Involvement of CX3CR1-Mediated Signals in the Bactericidal Host Defense During Septic Peritonitis","volume":"181","author":"Ishida","year":"2008","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s13054-015-1125-0","article-title":"Plasma Fractalkine Is a Sustained Marker of Disease Severity and Outcome in Sepsis Patients","volume":"19","author":"Hoogendijk","year":"2015","journal-title":"Crit. Care"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"104569","DOI":"10.1016\/j.meegid.2020.104569","article-title":"Role of Fractalkine in promoting inflammation in sepsis-induced multiple organ dysfunction","volume":"85","author":"Chen","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1172\/JCI71307","article-title":"CX3CR1-Dependent Renal Macrophage Survival Promotes Candida Control and Host Survival","volume":"123","author":"Lionakis","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/IAI.02604-14","article-title":"CX3CR1 Is Dispensable for Control of Mucosal Candida Albicans Infections in Mice and Humans","volume":"83","author":"Break","year":"2015","journal-title":"Infect. Immun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An Updated Overview of Diabetic Nephropathy: Diagnosis, Prognosis, Treatment Goals and Latest Guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ki.1991.308","article-title":"Possible Role of Tumor Necrosis Factor and Interleukin-1 in the Development of Diabetic Nephropathy","volume":"40","author":"Hasegawa","year":"1991","journal-title":"Kidney Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"146154","DOI":"10.1155\/2012\/146154","article-title":"Inflammation in Diabetic Nephropathy","volume":"2012","author":"Lim","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11892-018-0984-6","article-title":"Role of the Immune System in Diabetic Kidney Disease","volume":"18","author":"Hickey","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Chen, Y., Liao, L., Wang, B., and Wu, Z. (2024). Identification and Validation of Immune and Cuproptosis\u2014Related Genes for Diabetic Nephropathy by Wgcna and Machine Learning. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1332279"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2700392","DOI":"10.1155\/2022\/2700392","article-title":"Gene-Based Network Analysis Reveals Prognostic Biomarkers Implicated in Diabetic Tubulointerstitial Injury","volume":"2022","author":"Wu","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/j.ajkd.2015.01.021","article-title":"Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings from the Chronic Renal Insufficiency Cohort (Cric) Study","volume":"66","author":"Shah","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/db10-0956","article-title":"Fractalkine Is a Novel Human Adipochemokine Associated with Type 2 Diabetes","volume":"60","author":"Shah","year":"2011","journal-title":"Diabetes"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1159\/000077594","article-title":"Fractalkine and Its Receptor, CX3CR1, Upregulation in Streptozotocin-Induced Diabetic Kidneys","volume":"97","author":"Kikuchi","year":"2004","journal-title":"Nephron Exp. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJM197608192950805","article-title":"The Pathogenesis of Atherosclerosis (Second of Two Parts)","volume":"295","author":"Ross","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1054-8807(02)00111-4","article-title":"Characterization of Fractalkine (CX3CL1) and CX3CR1 in Human Coronary Arteries with Native Atherosclerosis, Diabetes Mellitus, and Transplant Vascular Disease","volume":"11","author":"Wong","year":"2002","journal-title":"Cardiovasc. Pathol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Stolla, M., Pelisek, J., von Br\u00fchl, M.L., Sch\u00e4fer, A., Barocke, V., Heider, P., Lorenz, M., Tirniceriu, A., Steinhart, A., and Bauersachs, J. (2012). Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043572"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/CIRCULATIONAHA.107.743872","article-title":"Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2\u2212\/\u2212 Mice: Evidence for Independent Chemokine Functions in Atherogenesis","volume":"117","author":"Saederup","year":"2008","journal-title":"Circulation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/CIRCULATIONAHA.107.745091","article-title":"Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6cHi and Ly6cLo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice","volume":"117","author":"Potteaux","year":"2008","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"913678","DOI":"10.1155\/2014\/913678","article-title":"Two Polymorphisms in the Fractalkine Receptor CX3CR1 Gene Influence the Development of Atherosclerosis: A Meta-Analysis","volume":"2014","author":"Wu","year":"2014","journal-title":"Dis. Markers"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1038\/s41467-020-19763-0","article-title":"Prevention of Cacl2-Induced Aortic Inflammation and Subsequent Aneurysm Formation by the CCL3-CCR5 Axis","volume":"11","author":"Ishida","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Nosaka, M., Ishida, Y., Kimura, A., Kuninaka, Y., Taruya, A., Ozaki, M., Tanaka, A., Mukaida, N., and Kondo, T. (2019). Crucial Involvement of IL-6 in Thrombus Resolution in Mice Via Macrophage Recruitment and the Induction of Proteolytic Enzymes. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.03150"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1161\/ATVBAHA.118.311194","article-title":"Contribution of the Tnf-A (Tumor Necrosis Factor-A)-Tnf-Rp55 (Tumor Necrosis Factor Receptor P55) Axis in the Resolution of Venous Thrombus","volume":"38","author":"Nosaka","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1172\/JCI40782","article-title":"Absence of Ifn-\u0393 Accelerates Thrombus Resolution through Enhanced Mmp-9 and Vegf Expression in Mice","volume":"121","author":"Nosaka","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1253\/circj.CJ-09-0484","article-title":"Upregulation of Fractalkine and Its Receptor, CX3CR1, Is Associated with Coronary Plaque Rupture in Patients with Unstable Angina Pectoris","volume":"74","author":"Ikejima","year":"2010","journal-title":"Circ. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1253\/circj.CJ-11-1457","article-title":"Independent Roles of Monocyte Chemoattractant Protein-1, Regulated on Activation, Normal T-Cell Expressed and Secreted and Fractalkine in the Vulnerability of Coronary Atherosclerotic Plaques","volume":"76","author":"Li","year":"2012","journal-title":"Circ. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cyto.2018.10.006","article-title":"Prognostic Value of Fractalkine\/CX3CL1 Concentration in Patients with Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention","volume":"113","author":"Xu","year":"2019","journal-title":"Cytokine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1113\/EP085104","article-title":"Fractalkine Neutralization Improves Cardiac Function after Myocardial Infarction","volume":"100","author":"Gu","year":"2015","journal-title":"Exp. Physiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1038\/s41467-022-35331-0","article-title":"Targeting Cardiomyocyte Adam10 Ectodomain Shedding Promotes Survival Early after Myocardial Infarction","volume":"13","author":"Klapproth","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biomaterials.2015.07.059","article-title":"A Novel CX3CR1 Antagonist Eluting Stent Reduces Stenosis by Targeting Inflammation","volume":"69","author":"Ali","year":"2015","journal-title":"Biomaterials"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Loh, S.X., Ekinci, Y., Spray, L., Jeyalan, V., Olin, T., Richardson, G., Austin, D., Alkhalil, M., and Spyridopoulos, I. (2023). Fractalkine Signalling (Cx(3)Cl1\/Cx(3)Cr1 Axis) as an Emerging Target in Coronary Artery Disease. J. Clin. Med., 12.","DOI":"10.3390\/jcm12144821"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab Plus Ipilimumab Versus Sunitinib in Advanced Renal-Cell Carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJMoa2035716","article-title":"Lenvatinib Plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma","volume":"384","author":"Motzer","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1816047","article-title":"Avelumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma","volume":"380","author":"Motzer","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e175949","DOI":"10.1172\/JCI175949","article-title":"Interruption of Klf5 Acetylation Promotes Pten-Deficient Prostate Cancer Progression by Reprogramming Cancer-Associated Fibroblasts","volume":"134","author":"Zhang","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-03-3437","article-title":"CX3CR1-Fractalkine Expression Regulates Cellular Mechanisms Involved in Adhesion, Migration, and Survival of Human Prostate Cancer Cells","volume":"64","author":"Shulby","year":"2004","journal-title":"Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"15213","DOI":"10.18632\/oncotarget.14773","article-title":"CX3CL1: A Potential Chemokine Widely Involved in the Process Spinal Metastases","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_99","first-page":"1544","article-title":"CX3CL1\/Fractalkine Enhances Prostate Cancer Spinal Metastasis by Activating the Src\/Fak Pathway","volume":"53","author":"Liu","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3892\/or.2015.4470","article-title":"CX3CL1 Increases Invasiveness and Metastasis by Promoting Epithelial-to-Mesenchymal Transition through the Tace\/Tgf-A\/Egfr Pathway in Hypoxic Androgen-Independent Prostate Cancer Cells","volume":"35","author":"Tang","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3892\/ijo.2012.1610","article-title":"Hypoxia Increases CX3CR1 Expression Via Hif-1 and Nf-\u039ab in Androgen-Independent Prostate Cancer Cells","volume":"41","author":"Xiao","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.3892\/mmr.2015.4438","article-title":"Upregulation of Fractalkine Contributes to The proliferative Response of Prostate Cancer Cells to Hypoxia Via Promoting the G1\/S Phase Transition","volume":"12","author":"Tang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1158\/1078-0432.CCR-08-1716","article-title":"Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer Following Prostatectomy","volume":"14","author":"Blum","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e173934","DOI":"10.1172\/JCI173934","article-title":"VHL Loss Reprograms the Immune Landscape to Promote an Inflammatory Myeloid Microenvironment in Renal Tumorigenesis","volume":"134","author":"Wolf","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4149\/neo_2022_211205N1728","article-title":"CX3CL1 in the Red Bone Marrow Promotes Renal Cell Carcinoma to Metastasize to the Spine by Involving the Src-Related Pathway","volume":"69","author":"Hu","year":"2022","journal-title":"Neoplasma"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Gong, Q., Guo, Z., Sun, W., Du, X., Jiang, Y., and Liu, F. (2022). CX3CL1 Promotes Cell Sensitivity to Ferroptosis and Is Associated with the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-10302-2"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Liu, H., Sun, S., Wang, G., Lu, M., Zhang, X., Wei, X., Gao, X., Huang, C., Li, Z., and Zheng, J. (2021). Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.663517"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12094-020-02431-6","article-title":"Clinical Significance of Expression Level of CX3CL1-CX3CR1 Axis in Bone Metastasis of Lung Cancer","volume":"23","author":"Liu","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.62347\/ONRF2499","article-title":"Establishment and Verification of a Predictive Model for Bone Metastasis in Patients with Non-Small Cell Lung Cancer Based on Peripheral Blood Cx3cl and Ccl28","volume":"14","author":"Li","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.7150\/thno.54235","article-title":"Vertebral-Specific Activation of the CX3CL1\/Icam-1 Signaling Network Mediates Non-Small-Cell Lung Cancer Spinal Metastasis by Engaging Tumor Cell-Vertebral Bone Marrow Endothelial Cell Interactions","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1080\/15384101.2022.2067438","article-title":"Suppression of CX3CL1 by Mir-497-5p Inhibits Cell Growth and Invasion through Inactivating the Erk\/Akt Pathway in Nsclc Cells","volume":"21","author":"Tang","year":"2022","journal-title":"Cell Cycle"},{"key":"ref_112","first-page":"4877","article-title":"Increased CX3CL1 Mrna Expression Level Is a Positive Prognostic Factor in Patients with Lung Adenocarcinoma","volume":"17","author":"Liu","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/mc.22787","article-title":"Differential Impact of CX3CL1 on Lung Cancer Prognosis in Smokers and Non-Smokers","volume":"57","author":"Su","year":"2018","journal-title":"Mol. Carcinog."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Liu, J., Ma, X., Liu, C., Cheng, Y., Li, B., Zhang, W., Zeng, R., Chen, Q., Zhang, Y., and Hu, S. (2023). Mesenchymal Stem Cells Elicits Anti-Pd1 Immunotherapy by Targeted Delivery of CX3CL1. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1136614"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"902","DOI":"10.4049\/jimmunol.1501335","article-title":"The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination","volume":"196","author":"Erreni","year":"2016","journal-title":"J. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.3748\/wjg.v23.i34.6212","article-title":"Circulating Inflammatory Factors Associated with Worse Long-Term Prognosis in Colorectal Cancer","volume":"23","author":"Olsen","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3892\/or.2015.3941","article-title":"Role of Chemokine CX3CL1 in Progression of Multiple Myeloma Via CX3CR1 in Bone Microenvironments","volume":"33","author":"Wada","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/iid3.53","article-title":"The Proportion of Cd16+Cd14Dim Monocytes Increases with Tumor Cell Load in Bone Marrow of Patients with Multiple Myeloma","volume":"3","author":"Sponaas","year":"2015","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Marchica, V., Toscani, D., Corcione, A., Bolzoni, M., Storti, P., Vescovini, R., Ferretti, E., Dalla Palma, B., Vicario, E., and Accardi, F. (2019). Bone Marrow CX3CL1\/Fractalkine Is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers, 11.","DOI":"10.3390\/cancers11030321"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ijlh.13963","article-title":"High CX3CR1 Expression Predicts Poor Prognosis in Paediatric Acute Myeloid Leukaemia Undergoing Hyperleukocytosis","volume":"45","author":"Mei","year":"2023","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"106443","DOI":"10.1016\/j.isci.2023.106443","article-title":"CX3CR1 Deficiency-Induced Til Tumor Restriction as a Novel Addition for Car-T Design in Solid Malignancies","volume":"26","author":"Trinh","year":"2023","journal-title":"iScience"}],"updated-by":[{"DOI":"10.3390\/ijms27093945","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000}}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/11\/5352\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:46:35Z","timestamp":1777455995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/11\/5352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":121,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ijms26115352"],"URL":"https:\/\/doi.org\/10.3390\/ijms26115352","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}